卡利拉嗪是一种非典型抗精神病药物，用于治疗精神分裂症和躁郁症。它主要作用于D3受体和D2受体部分激动剂，对D3受体具有高选择性。在2012年早期，针对精神分裂症和躁狂症，以及2015年II期试验中针对双相情感障碍I型抑郁症，发表了积极的III期研究结果。它也可能是有用的附加治疗抑郁症。
tert-Butyl piperazine-1-carboxylate
3-(trans-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-1,1-dimethylurea hydrochloride
1-Bromo-2,3-dichlorobenzene
tert-Butyl (trans-4-(2-hydroxyethyl)cyclohexyl)carbamate
Ethyl 2-(trans-4-((tert-butoxycarbonyl)amino)cyclohexyl)acetate
Ethyl 2-(diethoxyphosphoryl)acetate
4-Nitrophenylacetic acid
tert-Butyl (trans-4-(2-oxoethyl)cyclohexyl)carbamate
trans-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)cyclohexan-1-amine
4-Aminocyclohexanone
ethyl 2-[(1r,4r)-4-[(dimethylcarbamoyl)amino]cyclohexyl]acetate
3,3-dimethyl-1-[(1r,4r)-4-(2-oxoethyl)cyclohexyl]urea
3-(trans-4-(2-Hydroxyethyl)cyclohexyl)-1,1-dimethylurea
tert-Butyl ((1R,4R)-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)carbamate
